NADPH (tetracyclohexanamine)

• Description :

  NADPH tetracyclohexanamine functions as an important cofactor in a variety of metabolic and biosynthetic pathways. NADPH tetracyclohexanamine is an endogenous inhibitor of ferroptosis. NADPH tetracyclohexanamine plays a vital role in the biosynthesis of agents, chiral alcohols, fatty acids and biopolymers, while also being required for lipid biosynthesis, biomass formation, and cell replication[1][2][3][4].

• CAS Number :

  [100929-71-3]

• UNSPSC :

  12352005

• Target :

  Endogenous Metabolite; Ferroptosis

• Related Pathways :

  Apoptosis; Metabolic Enzyme/Protease

• Field of Research :

  Cancer; Metabolic Disease

• Purity :

  99.86

• Solubility :

  DMSO : ≥ 84 mg/mL|H2O : ≥ 100 mg/mL

• Smiles :

  O[C@H]1[C@@H](O)[C@H](N2C=C(C(N)=O)CC=C2)O[C@@H]1COP(O)(OP(OC[C@@H]3[C@@H](O)[C@@H](OP(O)(O)=O)[C@H](N(C4=NC=N5)C=NC4=C5N)O3)(O)=O)=O.NC6CCCCC6.NC7CCCCC7.NC8CCCCC8.NC9CCCCC9

• Molecular Formula :

  C45H82N11O17P3

• Molecular Weight :

  1142.12

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, sealed storage, away from moisture)

• Scientific Category :

  Oligonucleotides

• Clinical Information :

  No Development Reported

• Isoform :

  Human Endogenous Metabolite